Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-(p-amylcinnamoyl) Anthranilic Acid (ACA) 是一种广谱磷脂酶 A2(PLA2) 抑制剂,也是TRP channel 的阻滞剂。ACA 也可逆的抑制钙离子激活氯通道 (calcium-activated chloride channels) ,在心律失常方面具有研究的潜力。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 266 | 现货 | ||
10 mg | ¥ 377 | 现货 | ||
25 mg | ¥ 622 | 现货 | ||
50 mg | ¥ 970 | 待询 | ||
100 mg | ¥ 1,730 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 683 | 现货 |
产品描述 | N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker. |
体外活性 | ACA modulates different TRP channels most probably by a direct interaction. Owing to its high potency and efficacy on TRPM2, ACA can serve, in combination with other blockers, as a pharmacological tool for studying H2O2-induced Ca2+ signalling and biological functions of TRPM2 channels in native cells[1].ACA is also an inhibitor of phospholipase A2, blocking the release of arachidonic acid when given at 50 μM[2]. |
细胞实验 | Measurements of [Ca2+]i were carried out on TRPM8-transfected HEK293 cells grown in 96-well microplates. Cells were loaded with 1?μm fluo-4 for 30?min at 37°C in a standard solution. Subsequently, the standard solution was exchanged for a solution containing 1?mm EGTA instead of 2?mm CaCl2, and plates were inserted into a fluorometric-imaging plate reader. The fluorescence was excited at 485?nm, emitted at 535?nm and corrected for the background fluorescence. Fluorescence values were measured after addition of ACA, menthol and 3?mm CaCl2 to the EGTA-containing solution. ACA, menthol and 3?mm CaCl2 were applied consecutively in the given order with a time delay of 2?min between each application[1]. |
别名 | 2-(3-(4-戊基苯基)丙烯酰胺基)苯甲酸, ACA |
分子量 | 337.41 |
分子式 | C21H23NO3 |
CAS No. | 110683-10-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (370.47 mM)
H2O: Insoluble
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9638 mL | 14.8188 mL | 29.6375 mL | 74.0938 mL |
5 mM | 0.5928 mL | 2.9638 mL | 5.9275 mL | 14.8188 mL | |
10 mM | 0.2964 mL | 1.4819 mL | 2.9638 mL | 7.4094 mL | |
20 mM | 0.1482 mL | 0.7409 mL | 1.4819 mL | 3.7047 mL | |
50 mM | 0.0593 mL | 0.2964 mL | 0.5928 mL | 1.4819 mL | |
100 mM | 0.0296 mL | 0.1482 mL | 0.2964 mL | 0.7409 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
N-(p-amylcinnamoyl) Anthranilic Acid 110683-10-8 Membrane transporter/Ion channel Metabolism Phospholipase TRP/TRPV Channel N(pamylcinnamoyl) Anthranilic Acid N (p amylcinnamoyl) Anthranilic Acid 2-(3-(4-戊基苯基)丙烯酰胺基)苯甲酸 inhibit TRP Channel ACA Transient receptor potential channels Inhibitor inhibitor